Targeted therapies work. They also have inherent mutational liabilities. We map the resistance landscape of investigational drugs during preclinical development, informing lead candidate prioritization and compound optimization.
Our team of scientists and researchers are leaders in the field of genomics and drug discovery.
We are committed to developing innovative solutions that advance drug discovery efforts in the fight against cancer.
We offer a range of services that support preclinical programs, from drug discovery to lead prioritization.
Sign up to be the first to know when our platform launches.
Copyright © 2023 Atlas Biologics LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.